-
Integrating Real-World Evidence Into Oncology HTA Submissions: Recent EU Examples
Sep 9, 2025, 16:22 PM -
Receipt of Biomarker Testing in Non-Small Cell Lung Cancer: Using Real-World Data to Identify Testing Gaps and Treatment Characteristics
Sep 9, 2025, 16:22 PM -
Treatment Patterns, Inadequate Disease Control, and Burden/Unmet Need Among Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results From the Adelphi Real-World Disease Specific Program
Sep 9, 2025, 16:22 PM -
Confidential Prices in NICE Health Technology Assessment: How Common Are They?
Sep 9, 2025, 16:22 PM -
Treatment Preferences in Adults With Chronic Spontaneous Urticaria Symptomatic on H1-Antihistamines in China: Insights From CHOICE-CSU 2 Study
Sep 9, 2025, 16:22 PM -
How Impactful Is Time to Next Treatment on Health Technology Assessment Outcomes in Indolent Cancers?
Sep 9, 2025, 16:22 PM -
Introducing the Parameter Outcome Overview Plot: A New Addition to the Sensitivity Analysis Armory for Economic Models
Sep 9, 2025, 16:22 PM -
Strong But Do They Ask for Help? Mental Health of Young Athletes
Sep 9, 2025, 16:22 PM -
Stop Ignoring Missing Patients the Hidden Impact of Ignoring Missing Data in Health State Utility Estimation
Sep 9, 2025, 16:22 PM -
Use of Encorafenib + Cetuximab EC in Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer (mCRC) in Real-World Settings: Data Visualization From a Pooled Dataset of European Observational Studies
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations
Sep 9, 2025, 16:22 PM -
Real-World Patient Characteristics and Outcomes Associated With Antibody Drug Conjugate Therapy: A Large Cohort Study
Sep 9, 2025, 16:22 PM -
Preventing Stunting Through Early Nutritional Intervention: Effectiveness and Economic Evaluation in Children With Weight Faltering
Sep 9, 2025, 16:22 PM -
Synthesizing Health Service Utilization Data for a Complex Intervention: A Case Study of Teledermatology
Sep 9, 2025, 16:22 PM -
Overall Survival Adjusted for Subsequent Treatments: A Review of Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Lung Cancer in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Registration and Access to Orphan Medicines in Türkiye: A Comparative Study With Poland and Germany
Sep 9, 2025, 16:22 PM -
Updated Projections of HPV Vaccine Coverage Growth in Europe: Are Countries on Track to Meet WHO's 2030 Target?
Sep 9, 2025, 16:22 PM -
Biomarker Levels in Patients With Crohn’s Disease Post-Advanced Therapy Induction: A Real-World Survey in Europe
Sep 9, 2025, 16:22 PM -
Out-of-Work Transitions in the European Population With Noncommunicable Diseases
Sep 9, 2025, 16:22 PM
